-
Posted: September 3rd, 2010, 6:00am CDT
Researchers at the University of California, San Diego School of Medicine have identified the molecular mechanism that makes omega-3 fatty acids so effective in reducing chronic inflammation and insulin resistance. The discovery could lead to development of a simple dietary remedy for many of the more than 23 million Americans suffering from diabetes and other conditions...
-
Posted: September 3rd, 2010, 4:00am CDT
Halozyme Therapeutics, Inc. (Nasdaq: HALO) announced the initiation of two Phase 2 Ultrafast Insulin treatment studies that utilize its rHuPH20 hyaluronidase enzyme (PH20) in combination with the two leading commercially available mealtime analogs: insulin aspart, the active ingredient in NovoLog®, and insulin lispro, the active ingredient in Humalog®...
-
Posted: September 3rd, 2010, 2:00am CDT
INFECTIOUS DISEASE: Modified adenovirus malaria vaccine works a treat in mice Malaria kills more than 1 million individuals each year. Despite intensive research, there is still no malaria vaccine approved for use. A team of researchers, led by Moriya Tsuji, at the Aaron Diamond AIDS Research Center, New York, has now designed a new vaccine that provides protection from malaria in mice...
-
Posted: September 2nd, 2010, 8:00am CDT
Two studies reveal that smokers may have a significantly lower risk of developing lung cancer and colorectal cancer with the drug metformin, which is commonly prescribed for diabetes type 2 treatment, the medical journal Cancer Prevention Research informs...
-
Posted: September 2nd, 2010, 6:00am CDT
News outlets report on how the delivery of health care is being changed by empowered patients. USA Today: "In the past, most patients placed their entire trust in the hands of their physician. Your doc said you needed a certain medical test, you got it. Not so much anymore. Though some doctors find the newer 'empowered' patients taxing, others ...
-
Posted: September 2nd, 2010, 3:00am CDT
pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in the development of sustained release back of the eye drug delivery systems for difficult-to-treat conditions, announced that its licensee, Alimera Sciences (NASDAQ:ALIM) has been notified that the U.S...
-
Posted: September 2nd, 2010, 3:00am CDT
Older adults with diabetes who have high blood pressure, walk slowly or lose their balance, or believe they're in bad health, are significantly more likely to have weaker memory and slower, more rigid cognitive processing than those without these problems, according to a new study published by the American Psychological Association...
-
Posted: September 2nd, 2010, 3:00am CDT
Sibutramine, brand name Meridia is an appetite suppressant, a weight loss pill. Editors at the NEJM (New England Journal of Medicine) write it is difficult for them to discern a "credible rationale for keeping this medication on the market", even though it is restricted for people without heart disease...
-
Posted: September 2nd, 2010, 2:00am CDT
A majority of adults in California are obese or overweight, and more than 2 million have been diagnosed with diabetes, according to a new study from the UCLA Center for Health Policy Research...
-
Posted: August 31st, 2010, 10:00am CDT
Iluvien(R) (fluocinolone acetonide intravitreal insert), an investigational sustained drug delivery system that releases sub-microgram levels of fluocinolone acetonide for DME (diabetic macular edema) treatment, has been accepted for filing and granted Priority Review States by the FDA (Food and Drug Administration, USA), Alimera Sciences, Inc. announced today...
-
Posted: August 30th, 2010, 12:00pm CDT
New research from the University of Chicago found that many middle-aged and older Americans with diabetes are sexually active but more likely to experience sexual problems compared with counterparts without diabetes...
-
Posted: August 29th, 2010, 3:00am CDT
Examination of a gene involved in cell signaling finds that four common variants of this gene are associated with the development of end-stage renal disease in Chinese patients with type 2 diabetes, according to a study in the August 25 issue of JAMA. Renal (kidney) failure is an important cause of death among patients with type 2 diabetes...
-
Posted: August 28th, 2010, 3:00am CDT
Wound Management Technologies, Inc. (OTC Bulletin Board: WNDM) announced that its subsidiary Wound Care Innovations, LLC has further expanded its rapidly growing coverage of the Florida wound care market with the addition of Central Medical Systems to its already extensive list of distributors and suppliers...
-
Posted: August 28th, 2010, 2:00am CDT
The results of a new scientific study from Oxford Brookes University show that the consumption of caloric beverages has different affects on short-term total energy intake in men and women...
-
Posted: August 28th, 2010, 2:00am CDT
A mother who breastfed her children has a considerably lower risk of developing Diabetes Type 2 when she is older, compared to women who breastfed or women who never gave birth, according to an article published in the American Journal of Medicine...
-
Posted: August 27th, 2010, 7:00am CDT
This year, thousands of people in communities across the country will join the movement to Stop Diabetes® by participating in the American Diabetes Association's Step Out: Walk to Fight Diabetes event...
-
Posted: August 27th, 2010, 5:00am CDT
Many middle-aged and older adults with diabetes are sexually active according to a study of nearly 2,000 people aged 57 to 85 presented in the September 2010 issue of the journal Diabetes Care...
-
Posted: August 27th, 2010, 5:00am CDT
Rising numbers of people who are resistant to insulin or who have type 2 diabetes may also have an increased risk of Alzheimer's disease according to a new study published in Neurology. The study of 135 people from Hisayma in Fukuoka found that protein that clumps in the brain of people with Alzheimer's disease was present in higher amounts in people who were insulin resistant...
-
Posted: August 27th, 2010, 3:00am CDT
Naringenin, an antioxidant derived from the bitter flavor of grapefruits and other citrus fruits, may cause the liver to break down fat while increasing insulin sensitivity, a process that naturally occurs during long periods of fasting...
-
Posted: August 27th, 2010, 2:00am CDT
A study led by U.S. Department of Agriculture (USDA) chemist Richard Anderson suggests that a water soluble extract of cinnamon, which contains antioxidative compounds, could help reduce risk factors associated with diabetes and heart disease...
-
Posted: August 27th, 2010, 2:00am CDT
In a joint study conducted by Helmholtz Zentrum Munchen, the German Center for Neurodegenerative Diseases (DZNE) and a research group at Karolinska Institutet in Stockholm, Sweden, researchers have now discovered that lipid peroxides* play a specific physiological role in the cell. Prior to this study, scientists had already established that accumulation of lipid peroxides* indicate cell stress...
-
Posted: August 26th, 2010, 10:00am CDT
Individuals with Type 2 diabetes or insulin resistance have a higher risk of developing Alzheimer's disease because they are more likely to develop plaques in the brain associated with Azheimer's, says a new report published in the medical journal Neurology, issued August 25th, 2010...
-
Posted: August 26th, 2010, 4:00am CDT
People with insulin resistance and type 2 diabetes appear to be at an increased risk of developing plaques in the brain that are associated with Alzheimer's disease, according to new research published in the August 25, 2010, issue of Neurology®, the medical journal of the American Academy of Neurology...
-
Posted: August 26th, 2010, 3:00am CDT
Tranzyme Pharma announced that John Wo, MD, Professor of Medicine, Director, Clinical Research, Division of Gastroenterology, Hepatology and Nutrition, University of Louisville, Louisville, KY, will present ulimorelin Phase 2 data at this year's Joint International NGM Meeting on Saturday, August 28, 2010. The conference is being held at the Westin Copley Place in Boston, MA...
-
Posted: August 26th, 2010, 2:00am CDT
Why is it that some people lose weight and body fat when they exercise and eat less and others don't? German researchers say MRI and magnetic resonance (MR) spectroscopy can provide the answer - and help predict who will benefit from lifestyle changes. Results of the study are published online and will appear in the November issue of the journal Radiology...
-
Posted: August 25th, 2010, 8:00am CDT
A new analysis of diabetes medications Avandia (rosiglitazone) and Actos (pioglitazone) revealed that the risk of heart attack and/or heart failure, or death were the same, approximately 4%. The study has been published in the latest issue of Circulation: Cardiovascular Quality and Outcomes, an American Heart Association journal. Takeda Pharmacuetical Co...
-
Posted: August 25th, 2010, 6:00am CDT
Cellonis Biotechnologies, a Beijing and HK-based medical research and application company, has recorded some remarkable results in the treatment of a twelve-year-old boy with diabetes using their stem cell therapy in a Beijing partner hospital...
-
Posted: August 25th, 2010, 5:00am CDT
In contrast to previous reports, the risks of the composite endpoint of heart attack, heart failure, both, or death were the same about 4 percent for patients taking the diabetes drugs rosiglitazone or pioglitazone, according to a study published in the American Heart Association journal Circulation: Cardiovascular Quality and Outcomes...
-
Posted: August 25th, 2010, 4:00am CDT
Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE), a company developing its needle-free Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system and its Prelude™ SkinPrep System for transdermal drug delivery, announced the completion of a clinical study of Prelude...
-
Posted: August 25th, 2010, 3:00am CDT
The script for two research teams inducted into the American Chemical Society (ACS) scientific "hall of fame" - the ACS Heroes of Chemistry - is a tale of two pills. One team invented a medication that helps people with diabetes control their blood sugar levels...